Deuterated Alkyl Sulfonium Salt Reagents; Importance of H/D Exchange Methods in Drug Discovery
ChemMedChem · 19.08.2024 · 19 (16)
DOI: 10.1002/cmdc.202400201 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 25.06.2024. Verfasst von Riku Ogasahara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Drug Discovery, Deuterium. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, JST SPRING, JSPS (MEXT grant in aid-for transformative research areas (B) Deuterium Science) KAKENHI.
Abstract (Originalsprache)
Deuterated drugs (heavy drugs) have recently been spotlighted as a new modality for small‐molecule drugs because the pharmacokinetics of pharmaceutical drugs can be enhanced by replacing C−H bonds with more stable C−D bonds at metabolic positions. Therefore, deuteration methods for drug candidates are a hot topic in medicinal chemistry. Among them, the H/D exchange reaction (direct transformation of C−H bonds to C−D bonds) is a useful and straightforward method for creating novel deuterated target molecules, and over 20 reviews on the synthetic methods related to H/D exchange reactions have been published in recent years. Although various deuterated drug candidates undergo clinical trials, approved deuterated drugs possess CD 3 groups in the same molecule. However, less diversification, except for the CD 3 group, is a problem for future medicinal chemistry. Recently, we developed various deuterated alkyl ( d n ‐alkyl) sulfonium salts based on the H/D exchange reaction of the corresponding hydrogen form using D 2 O as an inexpensive deuterium source to introduce CD 3 , CH 3 CD 2 , and ArCH 2 CD 2 groups into drug candidates. This concept summarises recent reviews related to H/D exchange reactions and novel reagents that introduce the CD 3 group, and our newly developed electrophilic d n ‐alkyl reagents are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan.
- Deuterium Science Research Unit, Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Yoshida, Sakyo-ku, Kyoto, 606-8501, Japan.
ORCID-Profile: Shuji Akai, Yoshinari Sawama
Förderung
- JSPS KAKENHI
- JST SPRING
- JSPS (MEXT grant in aid-for transformative research areas (B) Deuterium Science) KAKENHI
- Life Science and Drug Discovery (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED
- Takeda Science Foundation
- the Mochida Memorial Foundation for Medical and Pharmaceutical Research
Zitieren
APA
Ogasahara, R., Ban, K., Mae, M., Akai, S., & Sawama, Y. (2024). Deuterated Alkyl Sulfonium Salt Reagents; Importance of H/D Exchange Methods in Drug Discovery. ChemMedChem, 19(16). https://doi.org/10.1002/cmdc.202400201
Vancouver
Ogasahara R, Ban K, Mae M, Akai S, Sawama Y. Deuterated Alkyl Sulfonium Salt Reagents; Importance of H/D Exchange Methods in Drug Discovery. ChemMedChem. 2024;19(16). doi:10.1002/cmdc.202400201
BibTeX
@article{Ogasahara2024,
author = {Ogasahara, Riku and Ban, Kazuho and Mae, Miyu and Akai, Shuji and Sawama, Yoshinari},
title = {Deuterated Alkyl Sulfonium Salt Reagents; Importance of H/D Exchange Methods in Drug Discovery},
journal = {ChemMedChem},
year = {2024},
volume = {19},
number = {16},
doi = {10.1002/cmdc.202400201}
}
EUVIMED